Page 148 - Mployee Wellness Programs News Today

The Biogen amyotrophic lateral sclerosis drug, Qalsody, treats patients whose disease is driven by mutations to a gene called SOD1. It’s the first drug approved to target a genetic cause of ALS.

ARCH Venture Partners-backed Orbital Therapeutics’ is researching next-generation RNA medicines that offer advantages over currently available therapies. The startup’s three areas of focus are vaccines, protein replacement, and immunomodulation.

Between eight to 24 million people could lose Medicaid coverage during the redetermination process, which began April 1, according to Kaiser Family Foundation. To mitigate losses, several states have implemented policies like taking the full year to complete renewals and automating the process.

Kaiser Permanente announced that it expects to acquire Pennsylvania-based Geisinger Health. Kaiser’s move is part of a larger plan — Geisinger will be the first health system to join Risant Health, a new company Kaiser launched to operate nonprofit health systems under value-based care models. Kaiser said it expects to invest $5 billion in Risant and fold five or six health systems into the company over the next five years.

America’s Health Insurance Plans' new campaign aims to show how health insurers are working to create savings for Americans while also targeting Big Pharma (or more specifically drug manufacturers) for increasing drug costs. The ads will be distributed on TV, social media and streaming services.

CommonSpirit Health has co-developed a nurse residency program with Dignity Health Global Education. The program, which is designed to increase nurse retention, comes at a time when turnover rates for newly graduated nurses are at an all-time high. Through the program, the partners are aiming to increase newly graduated nurse retention by at least 20% at CommonSpirit.

MedCity News connected with Global Health Leader at EY, Aloha McBride, to share details on the company's upcoming survey on what consumers are looking for in value-based care.

A shift from fee-for-service payment models to value-based models is not an effective way to address the severe financial pressures that safety net hospitals are facing, experts argued at the HIMSS conference in Chicago. One called for a paradigmatic shift “away from cost savings and toward understanding where investments are needed.”

With more freight moving around the world than ever, combined with increased external circumstances causing supply chain disruptions, there’s never been such pressure on the success of temperature controlled logistics as there is now. MedCity News sat down with John Coleman, Business Unit Director at YSDS Life Science, to talk about the challenges of delivering temperature-sensitive goods and how to overcome them.

A health system's failure to offer patients with digital payment options could lead to slower collection times, create a disjointed patient financial experience, and result in decreased patient satisfaction and loyalty. At HIMSS23, Atrium Health's vice president of revenue cycle management shared how his system integrated payment into its digital front door and gave pointers to hospitals looking to do the same.